Compare PCRX & VLRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCRX | VLRS |
|---|---|---|
| Founded | 2006 | 2005 |
| Country | United States | Mexico |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Air Freight/Delivery Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2011 | N/A |
| Metric | PCRX | VLRS |
|---|---|---|
| Price | $20.56 | $9.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 8 |
| Target Price | ★ $35.33 | $9.60 |
| AVG Volume (30 Days) | ★ 1.0M | 556.6K |
| Earning Date | 02-26-2026 | 02-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.47 | N/A |
| Revenue | $716,791,000.00 | ★ $2,990,662,000.00 |
| Revenue This Year | $6.21 | N/A |
| Revenue Next Year | $8.26 | $11.07 |
| P/E Ratio | $43.50 | ★ N/A |
| Revenue Growth | ★ 3.14 | N/A |
| 52 Week Low | $18.80 | $3.49 |
| 52 Week High | $27.64 | $9.99 |
| Indicator | PCRX | VLRS |
|---|---|---|
| Relative Strength Index (RSI) | 36.14 | 61.47 |
| Support Level | $18.80 | $8.41 |
| Resistance Level | $21.12 | $9.67 |
| Average True Range (ATR) | 1.25 | 0.36 |
| MACD | -0.33 | -0.03 |
| Stochastic Oscillator | 22.98 | 82.36 |
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
Controladora Vuela Compania de Aviacion SAB de CV is a low-cost airline flying to Mexico, the United States, Central, and South America. It uses promotional fares to stimulate demand, and the base fares are priced to compete with long-distance bus fares in Mexico. Revenues from the air transportation of passengers are recognized earlier when the service is provided or when the non-refundable ticket expires on the date of the scheduled travel. Non-passenger revenues include revenues generated from other non-passenger services and cargo services. The Company has two geographic areas identified as domestic (Mexico) and international (United States of America, Central America, and South America).